{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:20:38Z","timestamp":1793067638247,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["330178"],"award-info":[{"award-number":["330178"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["355604"],"award-info":[{"award-number":["355604"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["337530"],"award-info":[{"award-number":["337530"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["338182"],"award-info":[{"award-number":["338182"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Strategic Funding of the University of Eastern Finland"},{"name":"Doctoral Programme in Molecular Medicine of the University of Eastern Finland"},{"name":"The Strategic Neuroscience Funding of the University of Eastern Finland"},{"DOI":"10.13039\/501100013840","name":"Biocenter Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013840","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer\u2019s Association","doi-asserted-by":"crossref","award":["ADSF-24-1284326-C"],"award-info":[{"award-number":["ADSF-24-1284326-C"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer\u2019s Association","doi-asserted-by":"crossref","award":["ADSF-24-1284326-C"],"award-info":[{"award-number":["ADSF-24-1284326-C"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer\u2019s Association","doi-asserted-by":"crossref","award":["ADSF-24-1284326-C"],"award-info":[{"award-number":["ADSF-24-1284326-C"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Bundesministerium f\u00fcr Bildung und Forschung grant","award":["01ED2007A"],"award-info":[{"award-number":["01ED2007A"]}]},{"name":"Innovative Medicines Initiative 2 Joint Undertaking which receives support from the European Union\u2019s Horizon 2020 research and innovation programme","award":["115975"],"award-info":[{"award-number":["115975"]}]},{"name":"Sigrid Juselius Foundation"},{"name":"JPco-fuND-2 \u2018Multinational research projects on Personalized Medicine for Neurodegenerative Diseases\u2019","award":["334802"],"award-info":[{"award-number":["334802"]}]},{"name":"JPco-fuND-2 \u2018Multinational research projects on Personalized Medicine for Neurodegenerative Diseases\u2019","award":["334802"],"award-info":[{"award-number":["334802"]}]},{"name":"JPco-fuND-2 \u2018Multinational research projects on Personalized Medicine for Neurodegenerative Diseases\u2019","award":["334802"],"award-info":[{"award-number":["334802"]}]},{"name":"the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany\u2019s Excellence Strategy within the framework of the Munich Cluster for Systems Neurology","award":["390857198"],"award-info":[{"award-number":["390857198"]}]},{"name":"the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany\u2019s Excellence Strategy within the framework of the Munich Cluster for Systems Neurology","award":["390857198"],"award-info":[{"award-number":["390857198"]}]},{"name":"Bundesministerium f\u00fcr Bildung und Forschung grant, ClinspectM","award":["FKZ161L0214C"],"award-info":[{"award-number":["FKZ161L0214C"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Phospholipase C gamma 2, proline 522 to arginine (PLC\u03b32-P522R) is a protective variant that reduces the risk of Alzheimer\u2019s disease (AD). Recently, it was shown to mitigate \u03b2-amyloid pathology in a 5XFAD mouse model of AD. Here, we investigated the protective functions of the PLC\u03b32-P522R variant in a less aggressive APP\/PS1 mouse model of AD and assessed the underlying cellular mechanisms using mouse and human microglial models.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The effects of the protective PLC\u03b32-P522R variant on microglial activation, AD-associated \u03b2-amyloid and neuronal pathologies, and behavioral changes were investigated in PLC\u03b32-P522R knock-in variant mice crossbred with APP\/PS1 mice. Transcriptomic, proteomic, and functional studies were carried out using microglia isolated from mice carrying the PLC\u03b32-P522R variant. Finally, microglia-like cell models generated from human blood and skin biopsy samples of PLC\u03b32-P522R variant carriers were employed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The PLC\u03b32-P522R variant decreased \u03b2-amyloid plaque count and coverage in female APP\/PS1 mice. Moreover, the PLC\u03b32-P522R variant promoted anxiety in these mice. The area of the microglia around \u03b2-amyloid plaques was also increased in mice carrying the PLC\u03b32-P522R variant, while \u03b2-amyloid plaque-associated neuronal dystrophy and the levels of certain cytokines, including IL-6 and IL-1\u03b2, were reduced. These alterations were revealed through [18F]FEPPA PET imaging and behavioral studies, as well as various cytokine immunoassays, transcriptomic and proteomic analyses, and immunohistochemical analyses using mouse brain tissues. In cultured mouse primary microglia, the PLC\u03b32-P522R variant reduced the size of lipid droplets. Furthermore, transcriptomic and proteomic analyses revealed that the PLC\u03b32-P522R variant regulated key targets and pathways involved in lipid metabolism, mitochondrial fatty acid oxidation, and inflammatory\/interferon signaling in acutely isolated adult mouse microglia and human monocyte-derived microglia-like cells. Finally, the PLC\u03b32-P522R variant also increased mitochondrial respiration in human iPSC-derived microglia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>These findings suggest that the PLC\u03b32-P522R variant exerts protective effects against \u03b2-amyloid and neuronal pathologies by increasing microglial responsiveness to \u03b2-amyloid plaques in APP\/PS1 mice. The changes observed in lipid\/fatty acid and mitochondrial metabolism revealed by the omics and metabolic assessments of mouse and human microglial models suggest that the protective effects of the PLC\u03b32-P522R variant are potentially associated with increased metabolic capacity of microglia.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12974-025-03387-6","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T03:36:41Z","timestamp":1741145801000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The protective PLC\u03b32-P522R variant mitigates Alzheimer\u2019s disease-associated pathologies by enhancing beneficial microglial functions"],"prefix":"10.1186","volume":"22","author":[{"given":"Mari","family":"Takalo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heli","family":"Jeskanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisia","family":"Rolova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inka","family":"Kervinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Hell\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Heikkinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hennariikka","family":"Koivisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimmo","family":"Jokivarsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan A.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esa-Mikko","family":"Koivum\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"M\u00e4kinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sini-Pauliina","family":"Juopperi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roosa-Maria","family":"Willman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Sinisalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorit","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henna","family":"J\u00e4ntti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Peitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Flie\u00dfbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teemu","family":"Kuulasmaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teemu","family":"Natunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Kemppainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pekka","family":"Poutiainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ville","family":"Leinonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarja","family":"Malm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henna","family":"Martiskainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annakaisa","family":"Haapasalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan F.","family":"Lichtenthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heikki","family":"Tanila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Haass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Rinne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jari","family":"Koistinaho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Hiltunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"3387_CR1","volume-title":"Calcium Signaling","author":"CA Bill","year":"2020","unstructured":"Bill CA, Vines CM, Phospholipase C. Calcium Signaling. Cham: Springer International Publishing; 2020."},{"issue":"9","key":"3387_CR2","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/ng.3916","volume":"49","author":"R Sims","year":"2017","unstructured":"Sims R, Van Der Lee SJ, Naj AC, Bellenguez C, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer\u2019s disease. Nat Genet. 2017;49(9):1373\u201384.","journal-title":"Nat Genet"},{"issue":"1","key":"3387_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13195-019-0469-0","volume":"11","author":"L Magno","year":"2019","unstructured":"Magno L, Lessard CB, Martins M, Lang V, Cruz P, Asi Y, et al. Alzheimer\u2019s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph. Alz Res Therapy. 2019;11(1):16.","journal-title":"Alz Res Therapy"},{"issue":"2","key":"3387_CR4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer\u2019s disease. J Cell Biol. 2018;217(2):459\u201372.","journal-title":"J Cell Biol"},{"issue":"7","key":"3387_CR5","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A unique microglia type associated with restricting development of alzheimer\u2019s disease. Cell. 2017;169(7):1276-1290.e17.","journal-title":"Cell"},{"issue":"8","key":"3387_CR6","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41593-020-0650-6","volume":"23","author":"BJ Andreone","year":"2020","unstructured":"Andreone BJ, Przybyla L, Llapashtica C, Rana A, Davis SS, Van Lengerich B, et al. Alzheimer\u2019s-associated PLC\u03b32 is a signaling node required for both TREM2 function and the inflammatory response in human microglia. Nat Neurosci. 2020;23(8):927\u201338.","journal-title":"Nat Neurosci"},{"issue":"1","key":"3387_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13024-020-00402-7","volume":"15","author":"M Takalo","year":"2020","unstructured":"Takalo M, Wittrahm R, Wefers B, Parhizkar S, Jokivarsi K, Kuulasmaa T, et al. The Alzheimer\u2019s disease-associated protective Plc\u03b32-P522R variant promotes immune functions. Mol Neurodegeneration. 2020;15(1):52.","journal-title":"Mol Neurodegeneration"},{"issue":"3","key":"3387_CR8","first-page":"416","volume":"26","author":"B Van Lengerich","year":"2023","unstructured":"Van Lengerich B, Zhan L, Xia D, Chan D, Joy D, Park JI, et al. A TREM2-activating antibody with a blood\u2013brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u2019s disease models. Nat Neurosci. 2023;26(3):416.","journal-title":"Nat Neurosci"},{"issue":"8006","key":"3387_CR9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41586-024-07185-7","volume":"628","author":"MS Haney","year":"2024","unstructured":"Haney MS, P\u00e1lovics R, Munson CN, Long C, Johansson PK, Yip O, et al. APOE4\/4 is linked to damaging lipid droplets in Alzheimer\u2019s disease microglia. Nature. 2024;628(8006):154\u201361.","journal-title":"Nature"},{"issue":"2","key":"3387_CR10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41593-019-0566-1","volume":"23","author":"J Marschallinger","year":"2020","unstructured":"Marschallinger J, Iram T, Zardeneta M, Lee SE, Lehallier B, Haney MS, et al. Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. Nat Neurosci. 2020;23(2):194\u2013208.","journal-title":"Nat Neurosci"},{"issue":"2","key":"3387_CR11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00401-019-02026-8","volume":"138","author":"SJ Van Der Lee","year":"2019","unstructured":"Van Der Lee SJ, et al. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer\u2019s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity. Acta Neuropathol. 2019;138(2):237\u201350.","journal-title":"Acta Neuropathol"},{"issue":"6","key":"3387_CR12","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00401-020-02138-6","volume":"139","author":"L Kleineidam","year":"2020","unstructured":"Kleineidam L, Chouraki V, Pr\u00f3chnicki T, van der Lee SJ, Madrid-M\u00e1rquez L, Wagner-Thelen H, et al. PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment. Acta Neuropathol. 2020;139(6):1025\u201344.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"3387_CR13","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, Grenier-Boley B, et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat Genet. 2019;51(3):414\u201330.","journal-title":"Nat Genet"},{"issue":"4","key":"3387_CR14","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, K\u00fc\u00e7\u00fckali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet. 2022;54(4):412\u201336.","journal-title":"Nat Genet"},{"key":"3387_CR15","doi-asserted-by":"publisher","unstructured":"Coulon A, Rabiller F, Takalo M, Roy A, Martiskainen H, Siedlecki-Wullich D, et al. Neuronal downregulation of PLCG2 impairs synaptic function and elicits Alzheimer disease hallmarks. 2024 https:\/\/doi.org\/10.1101\/2024.04.29.591575","DOI":"10.1101\/2024.04.29.591575"},{"issue":"10","key":"3387_CR16","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1002\/alz.12577","volume":"18","author":"C Claes","year":"2022","unstructured":"Claes C, England WE, Danhash EP, Kiani Shabestari S, Jairaman A, Chadarevian JP, et al. The P522R protective variant of PLCG2 promotes the expression of antigen presentation genes by human microglia in an Alzheimer\u2019s disease mouse model. Alzheimer\u2019s & Dementia. 2022;18(10):1765\u201378.","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"3387_CR17","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1016\/j.immuni.2023.08.008","volume":"9","author":"AP Tsai","year":"2023","unstructured":"Tsai AP, Dong C, Lin PBC, Oblak AL, Viana Di Prisco G, Wang N, et al. Genetic variants of phospholipase C-\u03b32 alter the phenotype and function of microglia and confer differential risk for Alzheimer\u2019s disease. Immunity. 2023;9:2121\u201336.","journal-title":"Immunity"},{"issue":"4","key":"3387_CR18","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201911227","volume":"12","author":"K Schlepckow","year":"2020","unstructured":"Schlepckow K, Monroe KM, Kleinberger G, Cantuti-Castelvetri L, Parhizkar S, Xia D, et al. Enhancing protective microglial activities with a dual function TREM 2 antibody to the stalk region. EMBO Mol Med. 2020;12(4): e11227.","journal-title":"EMBO Mol Med"},{"issue":"2","key":"3387_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/hmg\/ddh019","volume":"13","author":"JL Jankowsky","year":"2004","unstructured":"Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, et al. Mutant presenilins specifically elevate the levels of the 42 residue \u03b2-amyloid peptide in vivo: evidence for augmentation of a 42-specific \u03b3 secretase. Hum Mol Genet. 2004;13(2):159\u201370.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"3387_CR20","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.nucmedbio.2007.12.009","volume":"35","author":"AA Wilson","year":"2008","unstructured":"Wilson AA, Garcia A, Parkes J, McCormick P, Stephenson KA, Houle S, et al. Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptors. Nucl Med Biol. 2008;35(3):305\u201314.","journal-title":"Nucl Med Biol"},{"issue":"7944","key":"3387_CR21","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipil\u00e4 TP, Kristiansson K, Donner KM, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613(7944):508\u201318.","journal-title":"Nature"},{"issue":"421","key":"3387_CR22","doi-asserted-by":"publisher","first-page":"7635","DOI":"10.1126\/scitranslmed.aai7635","volume":"9","author":"KJ Ryan","year":"2017","unstructured":"Ryan KJ, White CC, Patel K, Xu J, Olah M, Replogle JM, et al. A human microglia-like cellular model for assessing the effects of neurodegenerative disease gene variants. Sci Transl Med. 2017;9(421):7635.","journal-title":"Sci Transl Med"},{"key":"3387_CR23","doi-asserted-by":"publisher","unstructured":"Martiskainen H, Willman RM, Heikkinen S, M\u00fcller SA, Sinisalo R, Takalo M, et al. Monoallelic TYROBP deletion is a novel risk factor for Alzheimer\u2019s disease. 2024. https:\/\/doi.org\/10.1101\/2024.05.09.24307099","DOI":"10.1101\/2024.05.09.24307099"},{"issue":"15","key":"3387_CR24","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114\u201320.","journal-title":"Bioinformatics"},{"issue":"1","key":"3387_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321.","journal-title":"Bioinformatics"},{"issue":"8","key":"3387_CR26","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkz114","volume":"47","author":"Y Liao","year":"2019","unstructured":"Liao Y, Smyth GK, Shi W. The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads. Nucleic Acids Res. 2019;47(8):e47\u2013e47.","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"3387_CR27","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"12","key":"3387_CR28","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1093\/bioinformatics\/bty895","volume":"35","author":"A Zhu","year":"2019","unstructured":"Zhu A, Ibrahim JG, Love MI. Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences. Bioinformatics. 2019;35(12):2084\u201392.","journal-title":"Bioinformatics"},{"issue":"43","key":"3387_CR29","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"3387_CR30","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database hallmark gene set collection. Cell Syst. 2015;1(6):417\u201325.","journal-title":"Cell Syst"},{"issue":"1","key":"3387_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","volume":"17","author":"V Demichev","year":"2020","unstructured":"Demichev V, Messner CB, Vernardis SI, Lilley KS, Ralser M. DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput. Nat Methods. 2020;17(1):41\u20134.","journal-title":"Nat Methods"},{"issue":"9","key":"3387_CR32","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1074\/mcp.M113.031591","volume":"13","author":"J Cox","year":"2014","unstructured":"Cox J, Hein MY, Luber CA, Paron I, Nagaraj N, Mann M. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction. Termed MaxLFQ Mol Cell Prot. 2014;13(9):2513\u201326.","journal-title":"Termed MaxLFQ Mol Cell Prot"},{"key":"3387_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/0471143030.cb0325s33","author":"JN Larocca","year":"2006","unstructured":"Larocca JN, Norton WT. Isolation of Myelin. CP Cell. Biology. 2006. https:\/\/doi.org\/10.1002\/0471143030.cb0325s33.","journal-title":"Biology"},{"issue":"8","key":"3387_CR34","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/nn.4325","volume":"19","author":"S Safaiyan","year":"2016","unstructured":"Safaiyan S, Kannaiyan N, Snaidero N, Brioschi S, Biber K, Yona S, et al. Age-related myelin degradation burdens the clearance function of microglia during aging. Nat Neurosci. 2016;19(8):995\u20138.","journal-title":"Nat Neurosci"},{"key":"3387_CR35","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.scr.2018.04.011","volume":"29","author":"M Peitz","year":"2018","unstructured":"Peitz M, Bechler T, Thiele CC, Veltel M, Bloschies M, Fliessbach K, et al. Blood-derived integration-free iPS cell line UKBi011-A from a diagnosed male Alzheimer\u2019s disease patient with APOE \u025b4\/\u025b4 genotype. Stem Cell Res. 2018;29:250\u20133.","journal-title":"Stem Cell Res"},{"key":"3387_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2021.102180","volume":"52","author":"B Schmid","year":"2021","unstructured":"Schmid B, Holst B, Clausen C, Bahnassawy L, Reinhardt P, Bakker MHM, et al. Generation of a set of isogenic iPSC lines carrying all APOE genetic variants (\u01902\/\u01903\/\u01904) and knock-out for the study of APOE biology in health and disease. Stem Cell Research. 2021;52: 102180.","journal-title":"Stem Cell Research"},{"issue":"2","key":"3387_CR37","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.neuron.2017.03.042","volume":"94","author":"EM Abud","year":"2017","unstructured":"Abud EM, Ramirez RN, Martinez ES, Healy LM, Nguyen CHH, Newman SA, et al. iPSC-derived human microglia-like cells to study neurological diseases. Neuron. 2017;94(2):278-293.e9.","journal-title":"Neuron"},{"issue":"9","key":"3387_CR38","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1038\/s41380-024-02529-1","volume":"29","author":"M Koskuvi","year":"2024","unstructured":"Koskuvi M, P\u00f6rsti E, Hewitt T, R\u00e4s\u00e4nen N, Wu YC, Trontti K, et al. Genetic contribution to microglial activation in schizophrenia. Mol Psychiatry. 2024;29(9):2622\u201333.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"3387_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13024-018-0297-x","volume":"13","author":"A McQuade","year":"2018","unstructured":"McQuade A, Coburn M, Tu CH, Hasselmann J, Davtyan H, Blurton-Jones M. Development and validation of a simplified method to generate human microglia from pluripotent stem cells. Mol Neurodegeneration. 2018;13(1):67.","journal-title":"Mol Neurodegeneration"},{"issue":"4","key":"3387_CR40","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1177\/0023677215615269","volume":"50","author":"X Li","year":"2016","unstructured":"Li X, Feng Y, Wu W, Zhao J, Fu C, Li Y, et al. Sex differences between APPswePS1dE9 mice in A-beta accumulation and pancreatic islet function during the development of Alzheimer\u2019s disease. Lab Anim. 2016;50(4):275\u201385.","journal-title":"Lab Anim"},{"issue":"9","key":"3387_CR41","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1177\/002215540004800906","volume":"48","author":"SD Styren","year":"2000","unstructured":"Styren SD, Hamilton RL, Styren GC, Klunk WE. X-34, A fluorescent derivative of congo red: a novel histochemical stain for alzheimer\u2019s disease pathology. J Histochem Cytochem. 2000;48(9):1223\u201332.","journal-title":"J Histochem Cytochem"},{"issue":"7638","key":"3387_CR42","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481\u20137.","journal-title":"Nature"},{"issue":"1","key":"3387_CR43","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neuron.2016.09.016","volume":"92","author":"P Yuan","year":"2016","unstructured":"Yuan P, Condello C, Keene CD, Wang Y, Bird TD, Paul SM, et al. TREM2 Haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron. 2016;92(1):252\u201364.","journal-title":"Neuron"},{"issue":"2","key":"3387_CR44","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00401-016-1558-9","volume":"132","author":"KR Sadleir","year":"2016","unstructured":"Sadleir KR, Kandalepas PC, Buggia-Pr\u00e9vot V, Nicholson DA, Thinakaran G, Vassar R. Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased A\u03b2 generation in Alzheimer\u2019s disease. Acta Neuropathol. 2016;132(2):235\u201356.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"3387_CR45","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1084\/jem.20151948","volume":"213","author":"Y Wang","year":"2016","unstructured":"Wang Y, Ulland TK, Ulrich JD, Song W, Tzaferis JA, Hole JT, et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J Exp Med. 2016;213(5):667\u201375.","journal-title":"J Exp Med"},{"issue":"1","key":"3387_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12640-012-9355-2","volume":"24","author":"JM Li","year":"2013","unstructured":"Li JM, Xue ZQ, Deng SH, Luo XG, Patrylo PR, Rose GW, et al. Amyloid plaque pathogenesis in 5XFAD mouse spinal cord: Retrograde transneuronal modulation after peripheral nerve injury. Neurotox Res. 2013;24(1):1\u201314.","journal-title":"Neurotox Res"},{"issue":"182","key":"3387_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106150","volume":"15","author":"R Mabrouk","year":"2023","unstructured":"Mabrouk R, Miettinen PO, Tanila H. Most dystrophic neurites in the common 5xFAD Alzheimer mouse model originate from axon terminals. Neurobiol Dis. 2023;15(182): 106150.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"3387_CR48","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41593-018-0296-9","volume":"22","author":"S Parhizkar","year":"2019","unstructured":"Parhizkar S, Arzberger T, Brendel M, Kleinberger G, Deussing M, Focke C, et al. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nat Neurosci. 2019;22(2):191\u2013204.","journal-title":"Nat Neurosci"},{"issue":"4","key":"3387_CR49","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1084\/jem.20171265","volume":"215","author":"JD Ulrich","year":"2018","unstructured":"Ulrich JD, Ulland TK, Mahan TE, Nystr\u00f6m S, Nilsson KP, Song WM, et al. ApoE facilitates the microglial response to amyloid plaque pathology. J Exp Med. 2018;215(4):1047\u201358.","journal-title":"J Exp Med"},{"issue":"1","key":"3387_CR50","doi-asserted-by":"publisher","first-page":"19842","DOI":"10.1038\/s41598-021-96144-7","volume":"11","author":"J Obst","year":"2021","unstructured":"Obst J, Hall-Roberts HL, Smith TB, Kreuzer M, Magno L, Di Daniel E, et al. PLC\u03b32 regulates TREM2 signalling and integrin-mediated adhesion and migration of human iPSC-derived macrophages. Sci Rep. 2021;11(1):19842.","journal-title":"Sci Rep"},{"issue":"10","key":"3387_CR51","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210227","volume":"218","author":"G Gouna","year":"2021","unstructured":"Gouna G, Klose C, Bosch-Queralt M, Liu L, Gokce O, Schifferer M, et al. TREM2-dependent lipid droplet biogenesis in phagocytes is required for remyelination. J Exp Med. 2021;218(10): e20210227.","journal-title":"J Exp Med"},{"issue":"3","key":"3387_CR52","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, Fatimy RE, et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47(3):566.","journal-title":"Immunity"},{"issue":"17","key":"3387_CR53","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020105603","volume":"40","author":"E Maguire","year":"2021","unstructured":"Maguire E, Menzies GE, Phillips T, Sasner M, Williams HM, Czubala MA, et al. PIP2 depletion and altered endocytosis caused by expression of Alzheimer\u2019s disease-protective variant PLC\u03b32 R522. EMBO J. 2021;40(17): e105603.","journal-title":"EMBO J"},{"issue":"8","key":"3387_CR54","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00018-022-04473-1","volume":"79","author":"S Solomon","year":"2022","unstructured":"Solomon S, Sampathkumar NK, Carre I, Mondal M, Chennell G, Vernon AC, et al. Heterozygous expression of the Alzheimer\u2019s disease-protective PLC\u03b32 P522R variant enhances A\u03b2 clearance while preserving synapses. Cell Mol Life Sci. 2022;79(8):453.","journal-title":"Cell Mol Life Sci"},{"issue":"21","key":"3387_CR55","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-024-03271-9","volume":"1","author":"HA Staley","year":"2024","unstructured":"Staley HA, Jernigan JE, Bolen ML, Titus AM, Neighbarger N, Cole C, et al. Alzheimer\u2019s disease-associated protective variant Plcg2-P522R modulates peripheral macrophage function in a sex-dimorphic manner. J Neuroinflammation. 2024;1(21):280.","journal-title":"J Neuroinflammation"},{"issue":"10","key":"3387_CR56","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1101\/lm.042812.116","volume":"23","author":"BA Silva","year":"2016","unstructured":"Silva BA, Gross CT, Gr\u00e4ff J. The neural circuits of innate fear: detection, integration, action, and memorization. Learn Mem. 2016;23(10):544\u201355.","journal-title":"Learn Mem"},{"issue":"28","key":"3387_CR57","doi-asserted-by":"publisher","first-page":"5594","DOI":"10.1523\/JNEUROSCI.0184-19.2019","volume":"39","author":"ML Lehmann","year":"2019","unstructured":"Lehmann ML, Weigel TK, Poffenberger CN, Herkenham M. The behavioral sequelae of social defeat require microglia and are driven by oxidative stress in mice. J Neurosci. 2019;39(28):5594\u2013605.","journal-title":"J Neurosci"},{"issue":"12","key":"3387_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.624538","volume":"25","author":"LH Fairley","year":"2021","unstructured":"Fairley LH, Wong JH, Barron AM. Mitochondrial regulation of microglial immunometabolism in alzheimer\u2019s disease. Front Immunol. 2021;25(12): 624538.","journal-title":"Front Immunol"},{"issue":"12","key":"3387_CR59","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/nn.3554","volume":"16","author":"SE Hickman","year":"2013","unstructured":"Hickman SE, Kingery ND, Ohsumi TK, Borowsky ML, Wang L, et al. The microglial sensome revealed by direct RNA sequencing. Nat Neurosci. 2013;16(12):1896\u2013905.","journal-title":"Nat Neurosci"},{"issue":"6","key":"3387_CR60","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","volume":"153","author":"C L\u00f3pez-Ot\u00edn","year":"2013","unstructured":"L\u00f3pez-Ot\u00edn C, Blasco MA, Partridge L, Serrano M, Kroemer G. The Hallmarks of Aging. Cell. 2013;153(6):1194\u2013217.","journal-title":"Cell"},{"key":"3387_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115962","volume":"170","author":"W Wei","year":"2024","unstructured":"Wei W, Zhang L, Xin W, Pan Y, Tatenhorst L, Hao Z, et al. TREM2 regulates microglial lipid droplet formation and represses post-ischemic brain injury. Biomed Pharmacother. 2024;170: 115962.","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"3387_CR62","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.bbalip.2018.06.010","volume":"1863","author":"S Senga","year":"2018","unstructured":"Senga S, Kobayashi N, Kawaguchi K, Ando A, Fujii H. Fatty acid-binding protein 5 (FABP5) promotes lipolysis of lipid droplets, de novo fatty acid (FA) synthesis and activation of nuclear factor-kappa B (NF-\u03baB) signaling in cancer cells. Biochim Biophys Acta. 2018;1863(9):1057\u201367.","journal-title":"Biochim Biophys Acta"},{"issue":"25","key":"3387_CR63","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.3748\/wjg.v26.i25.3577","volume":"26","author":"M Tardelli","year":"2020","unstructured":"Tardelli M. Monoacylglycerol lipase reprograms lipid precursors signaling in liver disease. WJG. 2020;26(25):3577\u201385.","journal-title":"WJG"},{"issue":"4","key":"3387_CR64","first-page":"607","volume":"1821","author":"A Khatchadourian","year":"2012","unstructured":"Khatchadourian A, Bourque SD, Richard VR, Titorenko VI, Maysinger D. Dynamics and regulation of lipid droplet formation in lipopolysaccharide (LPS)-stimulated microglia. Biochimica et Biophys Acta Mol Cell Biol Lipids. 2012;1821(4):607\u201317.","journal-title":"Biochimica et Biophys Acta Mol Cell Biol Lipids"},{"key":"3387_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106370","volume":"190","author":"CB Ryan","year":"2024","unstructured":"Ryan CB, Choi JS, Kang B, Herr S, Pereira C, Moraes CT, et al. PI3K signaling promotes formation of lipid-laden foamy macrophages at the spinal cord injury site. Neurobiol Dis. 2024;190: 106370.","journal-title":"Neurobiol Dis"},{"key":"3387_CR66","volume":"2","author":"D Bull","year":"1870","unstructured":"Bull D, Matte JC, Navarron CM, McIntyre R, Whiting P, Katan M, et al. 2024 The hypermorphic PLC\u03b32 S707Y variant dysregulates microglial cell function Insight into PLC\u03b32 activation in brain health and disease, and opportunities for therapeutic modulation. Biochim Biophys Acta. 1870;2: 166978.","journal-title":"Biochim Biophys Acta"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03387-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-025-03387-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03387-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T04:17:52Z","timestamp":1741148272000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-025-03387-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3387"],"URL":"https:\/\/doi.org\/10.1186\/s12974-025-03387-6","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"21 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animals were raised and handled at the Laboratory Animal Center of the University of Eastern Finland, Kuopio, Finland. All mouse studies were carried out in accordance with the guidelines of the European Community Council Directives 86\/609\/EEC and approved by the Regional State Administrative Agency and Project Authorization Board (ESAVI\/7315\/2024, EKS-004\u20132019). All study protocols concerning human samples were approved by the Medical Research Ethics Committee of Wellbeing Services County of North Savo (formerly the Medical Research Ethics Committee of North Savo Hospital District, 833\/2023, 123\/2016). Participant recontacting was approved by the Scientific Steering Committee of Auria Biobank (BB_2020-0062).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors have approved the final version of the manuscript and provided their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CH collaborates with Denali Therapeutics and is a member of the advisory boards of AviadoBio and Cure Ventures.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}